PDS Biotechnology Corporation (PDSB)

R&D Expenses

$15.70M

TTM · Period ending: · USD

PDSB logo

PDSB R&D Expenses

Latest reported$15.70M
PDSB TTM R&D Expenses ($17.84M → $15.70M)
High-resolution chart · PNG

PDSB r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

PDS Biotechnology Corporation R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
15,704,531
16,651,863
19,025,830
19,150,068
21,377,579
21,692,359
22,565,524
25,501,480
25,146,108
28,623,262
27,762,784
36,452,146
34,356,605
30,113,399
29,431,028
16,665,237
16,000,249
15,002,798
11,254,540
10,342,983
8,715,799
7,365,829
7,924,451
6,794,991
6,568,176
7,040,951
6,099,272
5,236,204
3,596,272
4,233,272
15,945,272
26,294,068
33,013,000
39,464,000
34,311,000
30,256,000
30,068,000
27,068,000
24,826,000
23,312,000
23,095,000
20,315,000
17,839,000
15,412,000
11,323,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.